Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study

Journal of the American Academy of Dermatology
Andrew N HannaGiorgos C Karakousis

Abstract

There is large variability in the risk of sentinel lymph node (SLN) positivity among patients with intermediate thickness melanoma (ITM), with a subgroup of patients exhibiting a low risk of nodal disease. To identify a group of patients with ITM for whom the risk of nodal disease is low. A retrospective cohort of patients with ITM who underwent wide excision and nodal evaluation from 2010 to 2013 was identified by using the National Cancer Database and analyzed for the presence of nodal disease. Classification and regression tree analysis identified the most important factors used in a model to identify groups at low risk of SLN positivity. Of 23,440 patients, 14.7% were found to have nodal metastasis. On classification and regression tree analysis, patients older than 55 years without lymphovascular invasion and with a lesion thickness less than 1.7 mm had an SLN positivity rate of 4.9%. A model using age and thickness in nonulcerated patients identified a low-risk subgroup with a corresponding SLN positivity rate of 4.7%. This was a retrospective study, and the model developed requires prospective validation. Patient age is an important factor in estimating risk of SLN in patients with ITM and may help identify patients with...Continue Reading

References

Dec 1, 1998·JAMA : the Journal of the American Medical Association·J Zhang, K F Yu
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Mar 3, 2004·Annals of Surgical Oncology·Celia ChaoKelly M McMasters
Jun 29, 2004·Journal of Surgical Oncology·Kelly M McMastersUNKNOWN Sunbelt Melanoma Trial
Mar 9, 2006·Annals of Surgical Oncology·Giorgos C KarakousisFrancis R Spitz
Sep 29, 2006·The New England Journal of Medicine·Donald L MortonUNKNOWN MSLT Group
Jan 10, 2008·Annals of Surgical Oncology·Karl Y BilimoriaClifford Y Ko
Sep 17, 2008·Archives of Surgery·Byron E WrightDonald L Morton
Oct 7, 2011·Annals of Surgery·Rajmohan MuraliRichard A Scolyer
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dale HanStanley P Leong
Feb 14, 2014·The New England Journal of Medicine·Donald L MortonUNKNOWN MSLT Group
Jul 29, 2015·Annals of Surgical Oncology·Edmund K BartlettGiorgos C Karakousis
Jul 18, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J A MoodyJ T Hardwicke

❮ Previous
Next ❯

Citations

May 2, 2019·JAMA Dermatology·Daniel G Coit
Apr 9, 2020·Archives of Dermatological Research·Cristina FortesP Michelozzi
Aug 9, 2019·Annals of Surgical Oncology·Michael E EggerKelly M McMasters
Jun 3, 2020·Surgical Oncology Clinics of North America·Adrienne B ShannonGiorgos C Karakousis
Jun 9, 2021·Clinical & Experimental Metastasis·Michael J CarrJonathan S Zager
Jul 24, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Titus J BrinkerJochen S Utikal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.